Lonza expands its Capsugel R&D offering

| By | Drug Manufacturing, Lonza

Capsule Delivery Solutions, part of Swiss-based Lonza Pharma & Biotech, is launching the Capsugel® Colorista™ product, a high-quality capsule based on an “all-colorants” formulation. This new capsule further expands the Lonza Capsugel R&D offering.

Colorista capsules contain a broad selection of colorants suitable for use in major markets, allowing pharmaceutical customers to have access to a wide array of colors, and are available in both Vcaps Plus (HPMC) and Coni-Snap gelatin.

Colorista capsules offer more than 150 color options in Coni-Snap gelatin capsules and more than 50 color options in Vcaps Plus capsules and are available in different sizes to enable the encapsulation of a wide range of doses and formulations.

Like all other products in the Capsugel portfolio, Colorista capsules rely on Color Lab services, as well as regulatory and compliance support, to help Lonza’s customers in the formulation, design and manufacturing of high-quality oral delivery solutions.

The addition of Colorista capsules broaden the already comprehensive pre-clinical and clinical portfolio of Capsugel empty capsules, providing solutions for the full drug product development process.

SOURCE: lonza
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.